Summary
Recently, we described a leprechaun patient with a genetically transmitted severe insulin resistance due to the absence of functional insulin receptors as inferred from the loss of insulin binding to the patients' fibroblasts and the impaired autophosphorylation of the β-chain of the receptor. This patient was homozygous for the genetic defect which was recently found to be a leucine to proline mutation at position 233 in the α-chain of the insulin receptor. In the present study we have examined insulin receptor functions in relatives of this patient. Some of these individuals are heterozygous for the genetic defect and have only one allele coding for a functional insulin receptor. Insulin binding to cultured fibroblasts from the heterozygous individuals is only 20–40% of control values indicating a Mendelian mode of inheritance of the binding defect. In contrast, insulin stimulated autophosphorylation of the β-chain of the insulin receptor shows normal values, indicating compensation mechanisms operating on this process. The stimulation of the basal level of 2-deoxyglucose uptake by insulin in fibroblasts from the homozygous patient is 1.2 fold whereas the heterozygous and control individuals show stimulation values of approximately 1.65 fold. Basal levels of 2-deoxyglucose uptake are similar in these fibroblasts. Oral glucose tolerance tests on the heterozygous individuals indicate an increased requirement for insulin of the target tissues as concluded from the tendency towards hyperinsulinaemia with no observed hyperglycaemia. The results show that individuals with a genetic lesion in the insulin receptor which leads to decreased insulin binding, have mild abnormalities in their glucose tolerance tests but do not seem to develop hyperglycaemia as seen in Type 2 (non-insulin-dependent) diabetes mellitus.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Yoshimasa Y, Seino S, Whittaker J, Kakehi T, Kosaki A, Kuzuya H, Imura H, Bell GI, Steiner DF (1988) Insulin-resistant diabetes due to a point mutation that prevents insulin-proreceptor processing. Science 240: 784–787
Kadowaki T, Bevins CL, Cama A, Ojamaa K, Marcus-Samuels B, Kadowaki H, Beitz L, McKeon C, Taylor SI (1988) Two mutant alleles of the insulin receptor gene in a patient with extreme insulin resistance. Science 240: 787–790
Klinkhamer MP, Groen NA, van der Zon GCM, Lindhout D, Krans HMJ, Möller W, Maassen JA (1989) A leucine to proline mutation in the insulin receptor in a family with insulin resistance. EMBO J 8: 2503–2507
Maassen JA, Klinkhamer MP, van der Zon GCM, Sips H, Möller W, Krans HMJ, Lindhout D, Beemer FA (1988) Fibroblasts from a leprechaun patient have defects in insulin binding and insulin receptor autophosphorylation. Diabetologia 31: 612–617
Chou CK, Dull TJ, Russell DS, Gerzi R, Lebwohl D, Ullrich A, Rosen OM (1987) Human insulin receptors mutated at the ATP binding site lack protein tyrosine kinase activity and fail to mediate post receptor effects of insulin. J Biol Chem 262: 1842–1847
White MF, Kahn CR (1984) The insulin receptor and tyrosine phosphorylation. The enzymes, Vol XVII. Academic Press, New York London, pp 247–309
Nijs HGT, Radder JK, Fröhlich M, Krans HMJ (1988) Insulin action is normalized in newly diagnosed type I diabetic patients after three months of insulin treatment. Metabolism 37: 473–478
Freidenberg GR, Henry RR, Klein HH, Reichart DR, Olefsky JM (1987) Decreased kinase activity of insulin receptors from adipocytes of non-insulin-dependent diabetic subjects. J Clin Invest 79: 240–250
Mohan V, Snehalatha C, Ramachandran A, Viswanathan R (1985) C-peptide responses to glucose load in maturity onset diabetes of the young. Diabetes Care 8: 69–72
Itoh M, Hirooka Y, Nihei N (1983) Response of plasma somatostatin- like immunoreactivity (SLI) to a 75 g oral glucose tolerance test in normal subject and patients with impaired glucose tolerance. Acta Endocrinol 104: 468–474
National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28: 1039–1057
Endo F, Nagata N, Priest JH, Longo N, Elsas II LJ (1987) Structural analysis of normal and mutant insulin receptors in fibroblasts cultured from families with leprechaunism. Am J Hum Genet 41: 402–417
Maassen JA, Klinkhamer MP, Odink RJH, Sips H, van der Zon GCM, Wieringa T, Krans HJM, Möller W (1988) Improper expression of insulin receptors on fibroblasts from a leprechaun patient. Eur J Biochem 172: 725–729
Caro JF, Ittoop O, Pories WJ, Meelheim D, Flickinger EG, Thomas F, Jenquin M, Silverman JF, Khazanie PG, Sinh MK (1986) Studies on the mechanism of insulin resistance in the liver from humans with non-insulin dependent diabetes mellitus. Insulin action and binding in isolated hepatocytes, insulin receptor structure and kinase activity. J Clin Invest 78: 249–258
Takayama S, White MF, Lauris V, Kahn CR (1984) Phorbol esters modulate insulin receptor phosphorylation and insulin actions in cultured hepatoma cells. Proc Natl Acad Sci USA 81: 7797–7801
Hollenbeck C, Reaven GM (1987) Variations in insulin-stimulated glucose uptake with normal glucose tolerance. J Clin Endocrinol Metab 64: 1169–1173
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37: 1595–1607
Garvey WT, Huecksteadt TP, Matthaei S, Olefsky JM (1988) Role of glucose transportes in the cellular insulin resistance of type II non-insulin-dependent diabetes mellitus. J Clin Invest 81: 1528–1536
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lekanne Deprez, R.H., Potter van Loon, B.J., van der Zon, G.C.M. et al. Individuals with only one allele for a functional insulin receptor have a tendency to hyperinsulinaemia but not to hyperglycaemia. Diabetologia 32, 740–744 (1989). https://doi.org/10.1007/BF00274534
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00274534